The Georgia Research Alliance (GRA) is a not-for-profit organization based in Atlanta, Georgia, established in 1990. Its mission is to enhance research and commercialization capabilities within Georgia's universities, thereby fostering the development of new companies and high-value jobs. GRA focuses on investing in seed, early, and late-stage startups that are driven by research and are based in Georgia. The organization primarily targets sectors such as information technology, healthcare, and life sciences, aiming to transform lives through innovation and entrepreneurship.
PNP Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for cancer treatment. Established in 2000 and headquartered in Birmingham, Alabama, the company utilizes a proprietary platform based on the selective expression of E. coli purine nucleoside phosphorylase. This patented enzyme facilitates the activation of various nucleoside prodrugs, leading to the production of active metabolites that exhibit significant anti-tumor activity. PNP Therapeutics aims to enhance cancer treatment by directly targeting tumor cells within a controlled environment, thereby improving patient outcomes.
PNP Therapeutics
Grant in 2018
PNP Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for cancer treatment. Established in 2000 and headquartered in Birmingham, Alabama, the company utilizes a proprietary platform based on the selective expression of E. coli purine nucleoside phosphorylase. This patented enzyme facilitates the activation of various nucleoside prodrugs, leading to the production of active metabolites that exhibit significant anti-tumor activity. PNP Therapeutics aims to enhance cancer treatment by directly targeting tumor cells within a controlled environment, thereby improving patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.